Ishita Drugs & Industries Ltd

BSE: 524400

112

total announcements

ISHITADR.BO · 15 min delayed

Key Stats · Yahoo Finance · as of 06 Nov 2026

Market Cap

₹23 Cr

P/E (TTM)

33.0

EPS (TTM)

₹2.36

52W Low

₹66.00

52W High

₹90.85

Dividend Yield

0.00%

Price / Book

1.9

Return on Equity

6.24%

Debt / Equity

0.0

Revenue (TTM)

₹12 Cr

Gross Margin

16.74%

Operating Margin

9.75%

Announcements Discussion

BSEResultResults3d ago

Ishita Drugs & Industries Ltd

Unaudited Financial Results of the Company for the quarter and half year ended 30th September, 2026 alongwith limited review report issued by the statutory auditors of the Company.

Ishita Drugs & Industries Ltd has announced its unaudited financial results for the quarter and half year ended 30th September, 2026, along with a limited review report from its statutory auditors. The company has also discussed its upgradation project for its manufacturing facility to comply with Revised Schedule M.

Read more →📎 1 attachment

BSEBoard MeetingResults3d ago

Ishita Drugs & Industries Ltd

Board of Directors of Ishita Drugs and Industries Limited, at its meeting held today i.e. Tuesday, 03rd November, 2026 have 1. Approved the Unaudited Financial Results of the Company for the quarter and half year ended 30th September, 2026 along with the Limited Review Report issued by the Statutory Auditors of the Company enclosed herewith. 2. Discussed the upgradation project of manufacturing facility for compliance with Revised Schedule M.

Ishita Drugs & Industries Ltd has announced its unaudited financial results for the quarter and half year ended 30th September, 2026, along with the Limited Review Report issued by the Statutory Auditors. The company has also discussed the upgradation project of its manufacturing facility for compliance with Revised Schedule M.

Read more →📎 1 attachment

BSEBoard MeetingResults28 Oct 2026

Ishita Drugs & Industries Ltd

Ishita Drugs & Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve 1. To consider, approve and take on record the Unaudited Financial Results of the Company for the quarter ended 30th September, 2026. 2. Any other matter with permission of the Chair.

Ishita Drugs & Industries Ltd has scheduled a Board Meeting on 03/11/2026 to consider and approve the Unaudited Financial Results for the quarter ended 30th September, 2026.

Read more →📎 1 attachment

BSECompany UpdateRegulatory13 Oct 2026

Ishita Drugs & Industries Ltd

Compliance Certificate under regulation 74(5) of SEBI(Depositories and Participants) Regulations, 2018 for the quarter ended 30th September, 2026 as attached.

Ishita Drugs & Industries Ltd has submitted a compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.

Read more →📎 1 attachment

BSECompany UpdateMgmt Change5 Oct 2026

Ishita Drugs and Industries Limited

Ishita Drugs and Industries Limited has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Ishita Drugs and Industries Limited has informed BSE about the re-appointment of a Non-Executive Non-Independent Director.

BSECompany UpdateMgmt Change5 Oct 2026

Ishita Drugs and Industries Limited

Ishita Drugs and Industries Limited has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Ishita Drugs and Industries Limited has informed BSE about the re-appointment of a Non-Executive Non-Independent Director.

BSECompany UpdateAuditor Change5 Oct 2026

Ishita Drugs and Industries Limited

Ishita Drugs and Industries Limited has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Ishita Drugs and Industries Limited has informed BSE about the re-appointment of its statutory auditor.

BSECompany UpdateAuditor Change5 Oct 2026

Ishita Drugs and Industries Limited

Ishita Drugs and Industries Limited has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Ishita Drugs and Industries Limited has informed BSE about the re-appointment of its Statutory Auditor.

BSECompany UpdateAuditor Change5 Oct 2026

Ishita Drugs and Industries Limited

Ishita Drugs and Industries Limited has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Ishita Drugs and Industries Limited has informed BSE about the re-appointment of its statutory auditor.

BSECompany UpdateMgmt Change5 Oct 2026

Ishita Drugs and Industries Limited

Ishita Drugs and Industries Limited has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Ishita Drugs and Industries Limited has informed BSE about the re-appointment of a Non-Executive Non-Independent Director.

BSECompany UpdateAuditor Change5 Oct 2026

Ishita Drugs and Industries Limited

Ishita Drugs and Industries Limited has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Ishita Drugs and Industries Limited has informed BSE about the re-appointment of its Statutory Auditor.

BSECompany UpdateMgmt Change5 Oct 2026

Ishita Drugs and Industries Limited

Ishita Drugs and Industries Limited has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Ishita Drugs and Industries Limited has informed BSE about the re-appointment of a Non-Executive Non-Independent Director.

BSECompany UpdateMgmt Change5 Oct 2026

Ishita Drugs and Industries Limited

Ishita Drugs and Industries Limited has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Ishita Drugs and Industries Limited has informed BSE about the re-appointment of a Non-Executive Non-Independent Director.

BSECompany UpdateMgmt Change5 Oct 2026

Ishita Drugs and Industries Limited

Ishita Drugs and Industries Limited has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Ishita Drugs and Industries Limited has informed BSE about the re-appointment of a Non-Executive Non-Independent Director.

BSECompany UpdateMgmt Change5 Oct 2026

Ishita Drugs and Industries Limited

Ishita Drugs and Industries Limited has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Ishita Drugs and Industries Limited has informed BSE about the re-appointment of a Non-Executive Non-Independent Director.

BSECompany UpdateAuditor Change5 Oct 2026

Ishita Drugs and Industries Limited

Ishita Drugs and Industries Limited has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Ishita Drugs and Industries Limited has informed BSE about the re-appointment of its statutory auditor.

BSECompany UpdateMgmt Change5 Oct 2026

Ishita Drugs and Industries Limited

Ishita Drugs and Industries Limited has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Ishita Drugs and Industries Limited has informed BSE about the re-appointment of a Non-Executive Non-Independent Director.

BSECompany UpdateAuditor Change5 Oct 2026

Ishita Drugs and Industries Limited

Ishita Drugs and Industries Limited has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Ishita Drugs and Industries Limited has informed BSE about the re-appointment of its statutory auditor.

BSECompany UpdateAuditor Change5 Oct 2026

Ishita Drugs and Industries Limited

Ishita Drugs and Industries Limited has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Ishita Drugs and Industries Limited has informed BSE about the re-appointment of its statutory auditor.

BSECompany UpdateMgmt Change5 Oct 2026

Ishita Drugs and Industries Limited

Ishita Drugs and Industries Limited has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Ishita Drugs and Industries Limited has informed BSE about the re-appointment of a Non-Executive Non-Independent Director.

Page 1 of 6Next →